NCT03237780 2026-03-18
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
NYU Langone Health
City of Hope Medical Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center